NO324041B1 - Fremgangsmate for ekstrahering av DNA, samt fremgangsmate for deteksjon av en DNA-inneholdende mikroorganisme i serum eller plasma. - Google Patents
Fremgangsmate for ekstrahering av DNA, samt fremgangsmate for deteksjon av en DNA-inneholdende mikroorganisme i serum eller plasma. Download PDFInfo
- Publication number
- NO324041B1 NO324041B1 NO20000539A NO20000539A NO324041B1 NO 324041 B1 NO324041 B1 NO 324041B1 NO 20000539 A NO20000539 A NO 20000539A NO 20000539 A NO20000539 A NO 20000539A NO 324041 B1 NO324041 B1 NO 324041B1
- Authority
- NO
- Norway
- Prior art keywords
- plasma
- serum
- dna
- approx
- alkalinized
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 90
- 210000002966 serum Anatomy 0.000 title claims abstract description 77
- 244000005700 microbiome Species 0.000 title claims abstract description 17
- 239000006228 supernatant Substances 0.000 claims abstract description 22
- 239000003513 alkali Substances 0.000 claims abstract description 17
- 238000010438 heat treatment Methods 0.000 claims abstract description 12
- 230000003321 amplification Effects 0.000 claims description 25
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 25
- 238000001514 detection method Methods 0.000 claims description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 17
- 239000000047 product Substances 0.000 claims description 15
- 238000005119 centrifugation Methods 0.000 claims description 8
- 241000701024 Human betaherpesvirus 5 Species 0.000 claims description 7
- 241000894006 Bacteria Species 0.000 claims description 3
- 239000003155 DNA primer Substances 0.000 claims description 3
- 241000700605 Viruses Species 0.000 claims description 3
- 108020004414 DNA Proteins 0.000 description 54
- 238000003752 polymerase chain reaction Methods 0.000 description 30
- 229920000642 polymer Polymers 0.000 description 29
- 239000000523 sample Substances 0.000 description 27
- 239000011324 bead Substances 0.000 description 17
- 239000011541 reaction mixture Substances 0.000 description 14
- 210000000265 leukocyte Anatomy 0.000 description 10
- 239000013612 plasmid Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 239000003112 inhibitor Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 238000012408 PCR amplification Methods 0.000 description 7
- 238000003556 assay Methods 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000007400 DNA extraction Methods 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 108020004707 nucleic acids Proteins 0.000 description 5
- 102000039446 nucleic acids Human genes 0.000 description 5
- 150000007523 nucleic acids Chemical class 0.000 description 5
- 239000013615 primer Substances 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 238000005464 sample preparation method Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000011109 contamination Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000009396 hybridization Methods 0.000 description 4
- 239000013610 patient sample Substances 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000009089 cytolysis Effects 0.000 description 3
- 230000002452 interceptive effect Effects 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108060003393 Granulin Proteins 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 238000002944 PCR assay Methods 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 108010006785 Taq Polymerase Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 108091008048 CMVpp65 Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 241000450599 DNA viruses Species 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 206010058874 Viraemia Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001739 density measurement Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000013101 initial test Methods 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 238000007834 ligase chain reaction Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 238000002205 phenol-chloroform extraction Methods 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11849699P | 1999-02-03 | 1999-02-03 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20000539D0 NO20000539D0 (no) | 2000-02-02 |
| NO20000539L NO20000539L (no) | 2000-08-04 |
| NO324041B1 true NO324041B1 (no) | 2007-07-30 |
Family
ID=22378966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20000539A NO324041B1 (no) | 1999-02-03 | 2000-02-02 | Fremgangsmate for ekstrahering av DNA, samt fremgangsmate for deteksjon av en DNA-inneholdende mikroorganisme i serum eller plasma. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6268127B1 (de) |
| EP (1) | EP1026241B1 (de) |
| JP (1) | JP4468534B2 (de) |
| KR (1) | KR100845949B1 (de) |
| CN (1) | CN100334102C (de) |
| AT (1) | ATE267251T1 (de) |
| AU (1) | AU769709C (de) |
| CA (1) | CA2297547C (de) |
| DE (1) | DE60010776T2 (de) |
| DK (1) | DK1026241T3 (de) |
| ES (1) | ES2220340T3 (de) |
| NO (1) | NO324041B1 (de) |
| PT (1) | PT1026241E (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20020028386A (ko) * | 2000-10-09 | 2002-04-17 | 박제철 | 소량의 동물조직으로부터 미토콘드리아 디.엔.에이의순수분리 방법 |
| AU2003287082A1 (en) * | 2002-10-11 | 2004-05-04 | Imutex Pharmaceuticals, Inc. | Heterologous plasma cocktail for hiv treatment |
| CN107920789A (zh) * | 2015-05-25 | 2018-04-17 | 卡尤迪生物科技宜兴有限公司 | 用于样品收集的装置和方法 |
| CN107683330A (zh) * | 2015-05-25 | 2018-02-09 | 卡尤迪生物科技（北京）有限公司 | 用于样品收集的装置和方法 |
| CN108795926A (zh) * | 2018-06-27 | 2018-11-13 | 中国农业科学院麻类研究所 | 一种dna模板快速制备方法 |
| WO2020075695A1 (ja) * | 2018-10-09 | 2020-04-16 | 公益財団法人筑波メディカルセンター | 微生物の検出方法 |
| JP7329912B2 (ja) * | 2018-10-09 | 2023-08-21 | 公益財団法人筑波メディカルセンター | 微生物の検出方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5229297A (en) | 1989-02-03 | 1993-07-20 | Eastman Kodak Company | Containment cuvette for PCR and method of use |
| US5089233A (en) | 1989-06-12 | 1992-02-18 | Eastman Kodak Company | Processing apparatus for a chemical reaction pack |
| US5380489A (en) | 1992-02-18 | 1995-01-10 | Eastman Kodak Company | Element and method for nucleic acid amplification and detection using adhered probes |
| CA2137563C (en) | 1992-06-08 | 2005-06-28 | Thomas B. Ryder | Preparation of nucleic acid from mononuclear cells |
| US5582988A (en) | 1994-09-15 | 1996-12-10 | Johnson & Johnson Clinical Diagnostics, Inc. | Methods for capture and selective release of nucleic acids using weakly basic polymer and amplification of same |
| CA2248981C (en) * | 1996-03-15 | 2009-11-24 | The Penn State Research Foundation | Detection of extracellular tumor-associated nucleic acid in blood plasma or serum using nucleic acid amplification assays |
-
2000
- 2000-01-28 US US09/493,352 patent/US6268127B1/en not_active Expired - Lifetime
- 2000-02-01 CA CA002297547A patent/CA2297547C/en not_active Expired - Fee Related
- 2000-02-01 EP EP00300762A patent/EP1026241B1/de not_active Expired - Lifetime
- 2000-02-01 ES ES00300762T patent/ES2220340T3/es not_active Expired - Lifetime
- 2000-02-01 DE DE60010776T patent/DE60010776T2/de not_active Expired - Lifetime
- 2000-02-01 DK DK00300762T patent/DK1026241T3/da active
- 2000-02-01 AT AT00300762T patent/ATE267251T1/de active
- 2000-02-01 PT PT00300762T patent/PT1026241E/pt unknown
- 2000-02-02 KR KR1020000005130A patent/KR100845949B1/ko not_active IP Right Cessation
- 2000-02-02 NO NO20000539A patent/NO324041B1/no not_active IP Right Cessation
- 2000-02-02 AU AU14880/00A patent/AU769709C/en not_active Ceased
- 2000-02-03 JP JP2000032644A patent/JP4468534B2/ja not_active Expired - Fee Related
- 2000-02-03 CN CNB001046985A patent/CN100334102C/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2297547A1 (en) | 2000-08-03 |
| CN100334102C (zh) | 2007-08-29 |
| EP1026241A1 (de) | 2000-08-09 |
| KR20000076596A (ko) | 2000-12-26 |
| ATE267251T1 (de) | 2004-06-15 |
| EP1026241B1 (de) | 2004-05-19 |
| JP2000279199A (ja) | 2000-10-10 |
| DK1026241T3 (da) | 2004-08-30 |
| JP4468534B2 (ja) | 2010-05-26 |
| KR100845949B1 (ko) | 2008-07-11 |
| PT1026241E (pt) | 2004-09-30 |
| AU769709C (en) | 2004-10-14 |
| NO20000539D0 (no) | 2000-02-02 |
| US6268127B1 (en) | 2001-07-31 |
| NO20000539L (no) | 2000-08-04 |
| DE60010776D1 (de) | 2004-06-24 |
| AU1488000A (en) | 2000-08-10 |
| ES2220340T3 (es) | 2004-12-16 |
| CA2297547C (en) | 2006-12-19 |
| DE60010776T2 (de) | 2005-05-12 |
| CN1270962A (zh) | 2000-10-25 |
| AU769709B2 (en) | 2004-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7601491B2 (en) | Pretreatment method for extraction of nucleic acid from biological samples and kits therefor | |
| Van Gelder | Applications of the polymerase chain reaction to diagnosis of ophthalmic disease | |
| US5231015A (en) | Methods of extracting nucleic acids and pcr amplification without using a proteolytic enzyme | |
| JP5399993B2 (ja) | 組織試料およびパラフィン包埋組織から核酸を抽出するための改良方法 | |
| JP5290987B2 (ja) | 核酸増幅用サンプルの調製方法及び調製キット | |
| JP2575290B2 (ja) | ミコバクテリアの試料処理方法 | |
| NO324041B1 (no) | Fremgangsmate for ekstrahering av DNA, samt fremgangsmate for deteksjon av en DNA-inneholdende mikroorganisme i serum eller plasma. | |
| JP7272202B2 (ja) | 標的核酸の検査方法および検査装置 | |
| CN113046484A (zh) | 用于检测非洲猪瘟病毒p72基因的引物探针、试剂盒及方法 | |
| RU2524115C2 (ru) | Способ специфичной детекции малопредставленных фракций рнк в в биологическом образце | |
| JP7385471B2 (ja) | Ｐｈｉ６内部対照組成物、装置、および方法 | |
| JPH099967A (ja) | 核酸合成法 | |
| US20220195541A1 (en) | Detecting a target nucleic acid in a biological sample | |
| WO2024162323A1 (ja) | 血液由来試料の処理方法 | |
| US20220136074A1 (en) | Isothermal amplification and ambient visualization in a single tube for the detection of sars-cov-2 using loop-mediated amplification and crispr technology | |
| CN103866045B (zh) | Hav检测 | |
| JPH04200400A (ja) | ヒト生体由来の試料からのウイルスゲノムの抽出法及び該ウイルスゲノムの検出法 | |
| JP2003174878A (ja) | 核酸合成法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |